Home

EDGAR ENGLEMAN

CIK 1227162 · last filed 2023-12-01

EDGAR ENGLEMAN is a corporate insider who has filed 28 SEC Form 4 insider transactions across 6 companies since 2014. The most recent filing shows the insider sold $129.0K of BOLT on Dec 1, 2023. Across all open-market trades the lifetime net is +$7.2M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions. 2 SEC filings were submitted jointly with Albert Cha.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.03M

Companies

6

Total Filings

28

Lifetime Open-Market Net

$7.17M

Filer Profile

Reported Address
575 HIGH STREET
STE 201
PALO ALTO, CA 94301
Related Filers
Albert Cha — 2 joint filings, latest 2014-11-20
Vivo Ventures Fund V, L.P. — 2 joint filings, latest 2014-11-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BOLT Director 13,323 $3.95 $52.6K $3.82M 7 2023-12-01
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director 4,027,292 — — $2.00M 4 2018-02-07
SOLENO THERAPEUTICS INC (CAPNW) Delisted Director 14,652,610 — — $1.35M 2 2017-05-09
Eiger BioPharmaceuticals, Inc. (EIGR) Delisted Director — $1.73 — $0 3 2017-04-13
SOLENO THERAPEUTICS INC (CAPN.W) Delisted Director 9,823,011 — — $0 10 2016-06-10
RGNX Director 114,108 $8.53 $973.3K $0 2 2015-09-22

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2023-12-01 BOLT Sell (S) −148,884 -$129.0K EDGAR
2023-11-22 BOLT Sell (S) −1,943 -$1.8K EDGAR
2023-11-20 BOLT Sell (S) −49,173 -$45.7K EDGAR
2023-06-14 BOLT Grant (A) — $0 EDGAR
2022-06-10 BOLT Grant (A) — $0 EDGAR
2022-03-28 BOLT Grant (A) — $0 EDGAR
2021-02-09 BOLT Mixed +2,244,435 $4.00M EDGAR
2018-02-07 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +5,068 $8.7K EDGAR
2017-12-19 SOLENO THERAPEUTICS INC (SLNOW) Delisted Buy (P) +1,085,480 $2.00M EDGAR
2017-10-04 SOLENO THERAPEUTICS INC (SLNOW) Delisted Grant (A) +16,827 $8.8K EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.